What is the optimal first line antiretroviral therapy in resource-limited settings?
Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory, Cape Town, South Africa. chriskenyon0@gmail.com
Chris
C
Kenyon
Robert
R
Colebunders
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D038622:Internationality; D008297:Male; D011247:Pregnancy
D019380:Anti-HIV Agents